{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:52:45Z","timestamp":1780066365957,"version":"3.54.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Studies have shown that bortezomib resistance in multiple myeloma (MM) is mediated by the abnormalities of various molecules and microenvironments. Exploring these resistance mechanisms will improve the therapeutic efficacy of bortezomib. In this study, bone marrow tissues from three patients with MM, both sensitive and resistant to bortezomib, were collected for circRNA high-throughput sequencing analysis. The relationship between circ_0000337, miR-98-5p, and target gene DNA2 was analyzed by luciferase detection and verified by RT-qPCR. We first found that circ_0000337 was significantly upregulated in bortezomib-resistant MM tissues and cells, and overexpression of circ_0000337 could promote bortezomib resistance in MM cells. circ_0000337 may act as a miR-98-5p sponge to upregulate DNA2 expression, regulate DNA damage repair, and induce bortezomib resistance. Furthermore, it was determined that the increased circ_0000337 level in bortezomib-resistant cells was due to an increased N6-methyladenosine (m6A) level, resulting in enhanced RNA stability. In conclusion, the m6A level of circ_0000337 and its regulation may be a new and potential therapeutic target for overcoming bortezomib resistance in MM.<\/jats:p>","DOI":"10.3389\/fcell.2024.1383232","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T04:55:55Z","timestamp":1711083355000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["N6-methyladenosine-modified circ_0000337 sustains bortezomib resistance in multiple myeloma by regulating DNA repair"],"prefix":"10.3389","volume":"12","author":[{"given":"Siyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/bjh.17195","article-title":"Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma","volume":"193","author":"Abeykoon","year":"2021","journal-title":"Br. J. Haematol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/cancers15051526","article-title":"Periplocin overcomes bortezomib resistance by suppressing the growth and down-regulation of cell adhesion molecules in multiple myeloma","volume":"15","author":"Aziz","year":"2023","journal-title":"Cancers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"130299","DOI":"10.1016\/j.bbagen.2022.130299","article-title":"BDNF\/TrkB confers bortezomib resistance in multiple myeloma by inducing BRINP3","volume":"1867","author":"Bao","year":"2023","journal-title":"Biochimica biophysica acta. General Subj."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/S2352-3026(22)00360-X","article-title":"Upfront autologous transplantation still improving outcomes in patients with multiple myeloma","volume":"10","author":"Beksac","year":"2023","journal-title":"Lancet. Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41467-023-36747-y","article-title":"Inhibition of ALKBH5 attenuates I\/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41419-022-04651-w","article-title":"A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment","volume":"13","author":"Chroma","year":"2022","journal-title":"Cell death Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-023-38232-y","article-title":"Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1038\/s41467-020-19932-1","article-title":"Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma","volume":"11","author":"Federico","year":"2020","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.3390\/cancers13133154","article-title":"New molecular mechanisms and clinical impact of circRNAs in human cancer","volume":"13","author":"Fontemaggi","year":"2021","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8860728","DOI":"10.1155\/2021\/8860728","article-title":"Increased expression of DNA2 was linked to poor prognosis in breast cancer","volume":"2021","author":"Han","year":"2021","journal-title":"Dis. markers"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00277-023-05283-6","article-title":"m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2","volume":"102","author":"Huang","year":"2023","journal-title":"Ann. Hematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1038\/s41467-023-41223-8","article-title":"Disentangling age, gender, and racial\/ethnic disparities in multiple myeloma burden: a modeling study","volume":"14","author":"Huber","year":"2023","journal-title":"Nat. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.3390\/cancers14225575","article-title":"Extracellular vesicles in multiple myeloma-cracking the code to a better understanding of the disease","volume":"14","author":"Iskrzak","year":"2022","journal-title":"Cancers"},{"key":"B14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","article-title":"HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA","volume":"14","author":"Jiang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.6004\/jnccn.2023.0061","article-title":"Multiple myeloma, version 2.2024, NCCN clinical Practice guidelines in oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1038\/oncsis.2017.15","article-title":"Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells","volume":"6","author":"Kumar","year":"2017","journal-title":"Oncogenesis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41388-021-02167-9","article-title":"Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1","volume":"41","author":"Li","year":"","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-023-01811-0","article-title":"Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7","volume":"22","author":"Li","year":"","journal-title":"Mol. cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12033-022-00618-6","article-title":"Hsa_Circ_0134426 attenuates the malignant biological behaviors of multiple myeloma by suppressing miR-146b-3p to upregulate NDNF","volume":"65","author":"Li","year":"","journal-title":"Mol. Biotechnol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41467-021-21386-y","article-title":"Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13059-022-02621-1","article-title":"Accurate identification of circRNA landscape and complexity reveals their pivotal roles in human oligodendroglia differentiation","volume":"23","author":"Li","year":"","journal-title":"Genome Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12935-023-03028-z","article-title":"CircRNAs in diagnosis, prognosis, and clinicopathological features of multiple myeloma; a systematic review and meta-analysis","volume":"23","author":"Mirazimi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/cancers15174347","article-title":"Unlocking drug resistance in multiple myeloma: adipocytes as modulators of treatment response","volume":"15","author":"Ochiai","year":"2023","journal-title":"Cancers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.ymthe.2022.12.005","article-title":"CircRNAs regulate the crosstalk between inflammation and tumorigenesis: the bilateral association and molecular mechanisms","volume":"31","author":"Qadir","year":"2023","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e167629","DOI":"10.1172\/JCI167629","article-title":"Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy","volume":"133","author":"Robinson","year":"2023","journal-title":"J. Clin. investigation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1182\/blood.2021014635","article-title":"Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study","volume":"139","author":"Roussel","year":"2022","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1182\/blood.2020005885","article-title":"Progression signature underlies clonal evolution and dissemination of multiple myeloma","volume":"137","author":"Shen","year":"2021","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA a Cancer J. Clin."},{"key":"B29","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1038\/s41388-021-01939-7","article-title":"IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma","volume":"40","author":"Song","year":"2021","journal-title":"Oncogene"},{"key":"B30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s10038-022-01075-4","article-title":"DNA2 mutation causing multisystemic disorder with impaired mitochondrial DNA maintenance","volume":"67","author":"Sun","year":"","journal-title":"J. Hum. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"146824","DOI":"10.1016\/j.gene.2022.146824","article-title":"Construction of circRNA-associated ceRNA network reveals the regulation of fibroblast proliferation in cervical cancer","volume":"844","author":"Sun","year":"","journal-title":"Gene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e861","DOI":"10.1016\/S2352-3026(20)30323-9","article-title":"Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study","volume":"7","author":"Tacchetti","year":"2020","journal-title":"Lancet. Haematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13046-022-02276-7","article-title":"A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing","volume":"41","author":"Tang","year":"2022","journal-title":"J. Exp. Clin. cancer Res. CR"},{"key":"B34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.molcel.2022.12.026","article-title":"Exclusion of m6A from splice-site proximal regions by the exon junction complex dictates m6A topologies and mRNA stability","volume":"83","author":"Uzonyi","year":"2023","journal-title":"Mol. Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41417-022-00429-6","article-title":"FTO promotes Bortezomib resistance via m6A-dependent destabilization of SOD2 expression in multiple myeloma","volume":"30","author":"Wang","year":"2023","journal-title":"Cancer gene Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"215649","DOI":"10.1016\/j.canlet.2022.215649","article-title":"System Xc inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance","volume":"535","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10735-021-09983-z","article-title":"Up-regulation of DNA2 results in cell proliferation and migration in endometriosis","volume":"52","author":"Wang","year":"2021","journal-title":"J. Mol. histology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00018-022-04370-7","article-title":"The limited role of most circRNAs as sponges for microRNAs","volume":"79","author":"Wang","year":"2022","journal-title":"Cell. Mol. life Sci. CMLS"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s10528-022-10228-1","article-title":"CircATIC contributes to multiple myeloma progression via miR-324-5p-dependent regulation of HGF","volume":"60","author":"Wu","year":"2022","journal-title":"Biochem. Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11845-021-02586-3","article-title":"Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients","volume":"191","author":"Xiang","year":"2022","journal-title":"Ir. J. Med. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","article-title":"FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner","volume":"30","author":"Xu","year":"2022","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41392-021-00788-w","article-title":"Crosstalk between circRNAs and the PI3K\/AKT signaling pathway in cancer progression","volume":"6","author":"Xue","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"216219","DOI":"10.1016\/j.canlet.2023.216219","article-title":"CircRNAs in tumor immunity and immunotherapy: perspectives from innate and adaptive immunity","volume":"564","author":"Yu","year":"2023","journal-title":"Cancer Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.gendis.2020.07.011","article-title":"The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases","volume":"8","author":"Zhang","year":"","journal-title":"Genes & Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41392-021-00699-w","article-title":"m6A demethylase FTO attenuates cardiac dysfunction by regulating glucose uptake and glycolysis in mice with pressure overload-induced heart failure","volume":"6","author":"Zhang","year":"","journal-title":"Signal Transduct. Target. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41418-020-0600-6","article-title":"CircRNA-vgll3 promotes osteogenic differentiation of adipose-derived mesenchymal stem cells via modulating miRNA-dependent integrin \u03b15 expression","volume":"28","author":"Zhang","year":"","journal-title":"Cell death Differ."},{"key":"B47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12967-023-04240-1","article-title":"Hsa_circ_0002348 regulates trophoblast proliferation and apoptosis through miR-126-3p\/BAK1 axis in preeclampsia","volume":"21","author":"Zhou","year":"2023","journal-title":"J. Transl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"Zhuang","year":"2023","journal-title":"Mol. cancer"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1383232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T04:55:58Z","timestamp":1711083358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1383232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":48,"alternative-id":["10.3389\/fcell.2024.1383232"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2024.1383232","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"article-number":"1383232"}}